ZymoGenetics' IPO

ZymoGenetics raised a round of funding on February 01, 2002. Investors include Public.

Zymogenetics focuses on developing a pipeline of therapeutic proteins indulging Recothrom for hemostasis.…

Articles about ZymoGenetics' IPO: